This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: The University of Texas System, Oncolys Biopharma, Inc., Other. Active years: 1998-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Okayama JP (2003)
- Okayama-shi, Okayama JP (2006 - 2009)
- Okayama, JP (1998 - 2012)
Company Filing History:
4 out of 5,640 
2 out of 5 
3 out of 834,570 Years Active: 1998-2012
Title: The Innovative Contributions of Toshiyoshi Fujiwara in Cancer Research
Introduction
Toshiyoshi Fujiwara, located in Okayama, Japan, is a prominent inventor known for his significant advancements in the field of cancer research. With an impressive portfolio comprising 9 patents, Fujiwara has made remarkable contributions through his innovative approaches to cancer treatment and diagnosis.
Latest Patents
Among his latest inventions, Fujiwara developed a groundbreaking oncolytic virus that selectively replicates in tumor cells. This innovative virus utilizes a gene sequence that includes a telomerase promoter and an E1 gene, particularly featuring the E1A gene, IRES sequence, and E1B gene. By leveraging this viral mechanism, the virus exhibits the capability to efficiently target and destroy cancer cells.
Additionally, Fujiwara's work includes the Telomelysin/GFP-expressing recombinant virus. This invention serves as a reagent for cancer cell detection and diagnosis. The recombinant virus features a replication cassette integrated into the E1 region of the viral genome and a labeling cassette integrated into the E3 region, allowing for effective cancer cell identification.
Career Highlights
Throughout his career, Toshiyoshi Fujiwara has collaborated with leading institutions, including the Massachusetts Institute of Technology (MIT). His research endeavors demonstrate a strong commitment to uncovering innovative solutions in the battle against cancer.
Collaborations
Fujiwara's collaborative efforts include working alongside notable peers such as Noriaki Tanaka and Jack A. Roth. These collaborations have further enhanced his contributions to research and development in oncology.
Conclusion
Toshiyoshi Fujiwara's pioneering work and inventive spirit continue to make a significant impact in cancer research. His innovative patents not only advance the understanding of cancer treatment but also pave the way for future breakthroughs in the field. With a focus on targeting cancer cells using viral mechanisms, Fujiwara is at the forefront of transformative advancements that hold promise for better therapeutic outcomes for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile